Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, receptor-selectivity models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
Frequently Asked Questions
Explore answers to our most commonly asked questions about CBD, our products, and more.
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. It is supplied as a research peptide for endocrine signaling studies.